Session I - Screening Prevention Early-Stage Lung Cancer
By: David T. Cooke, MD, Ken Yoneda, MD, Heather Wakelee, MD, Johannes Kratz, MD, PhD, Megan Daly, MD
EGFR: Common and Uncommon Mutations and What Is Next for This Patient Population
By: Edgardo S Santos, MD, FACP
Liquid Biopsy: Advances in the Last Decade and Future Directions
By: Edgardo S. Santos Castillero, MD, FACP
Other Targetable Agents (KRASg 12c, BRafv600, RET and NTRK)
By: Edgardo S. Santos Castillero, MD, FACP
Liquid Biopsy: Advances in the Last Decade and Future Directions
By: Edgardo S. Santos Castillero, MD, FACP
Other Targetable Agents (KRASg 12c, BRafv600, RET and NTRK)
By: Edgardo S. Santos Castillero, MD, FACP
